Get in touch



April 2018: J. Schroeder Joins MicroProtein Technologies as Director of Quality

Mr. Schroeder serves as the Director of Quality, MicroProtein Technologies, Inc.  He has an A.S. degree (Chemistry) and >25 years of industrial experience in QC/QA in both the pharmaceutical and nuclear reactor power industries.  Mr. Schroeder joined the company in Jan. 2018 after 10 years at Wolf Creek Nuclear as a Chemist and then Certified Quality Auditor.  He previously spent 15 years with Novartis Pharmaceuticals working in Chemistry and Quality Assurance roles.  Read more about our quality and compliance programs that assure clients of the product highest quality and regulatory acceptance.

Advisory Board

April 2018: S.R. Rangineni, M.D., has Joined MicroProtein as Vice President of Business Development and Strategy

Sandeep R. Rangineni, M.D., has joined MicroProtein Technologies as Vice President of Business Development and Strategy.  Dr. Sandeep has multiple years experience working in the biologics field and cGMP manufacturing.  Dr. Sandeep also has prior experience treating cancer patients and is primary author of multiple related articles published in peer reviewed medical journals.  Dr Rangineni received his B.S. from The University of Kansas and medical degree from Windsor University School of Medicine, St Kitts.  His interests include staying current on new trends in the biologics industry, improving his golf swing, and following the local Kansas City sports teams.

Dr. Rangineni can be contacted by phone at 913-851-0877 or

Advisory Board